Close Asset Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20
Closed -$1K 271
2026
Q1
$1K Hold
20
﹤0.01% 264
2025
Q4
$2K Hold
20
﹤0.01% 258
2025
Q3
$2K Sell
20
-166
-89% -$12.4K ﹤0.01% 252
2025
Q2
$14K Sell
186
-14
-7% -$975 ﹤0.01% 211
2025
Q1
$16K Sell
200
-447
-69% -$38.4K ﹤0.01% 200
2024
Q4
$51K Hold
647
﹤0.01% 149
2024
Q3
$61K Sell
647
-883
-58% -$74.1K ﹤0.01% 151
2024
Q2
$119K Buy
1,530
+8
+0.5% +$653 ﹤0.01% 135
2024
Q1
$138K Buy
1,522
+447
+42% +$37.2K 0.01% 130
2023
Q4
$83K Hold
1,075
﹤0.01% 136
2023
Q3
$73K Buy
1,075
+100
+10% +$7.28K ﹤0.01% 134
2023
Q2
$79K Buy
975
+192
+25% +$15.3K ﹤0.01% 142
2023
Q1
$64K Buy
+783
New +$55.9K ﹤0.01% 137

Other funds holding GEHC

Close Asset Management's GEHC Position: Q2 2026 in Review

Close Asset Management sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 20 shares — an estimated $1K sold.

Close Asset Management first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $138K in Q1 2024. 1,225 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Close Asset Management reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Close Asset Management sold 20 GE HealthCare shares in Q2 2026, an estimated $1K.
  • Close Asset Management first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Close Asset Management's GE HealthCare position peaked at $138K in Q1 2024.
  • 1,225 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.